An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers

NCT ID: NCT05458050

Last Updated: 2023-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

433 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2023-08-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A double blind, non randomized, multicenter investigation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consists of 2 evaluations/visits.

Evaluation/visit 1: Takes place in connection with admission to the hospital. Informed consent, inclusion and exclusion criteria are assessed as well as assessment of skin type and inspection of the entire body skin. Pregnancy test on women of childbearing potential, height, weight, blood pressure and body temperature are measured. Questions about demography, health conditions, previous illnesses, nicotine habits. Risk assessment for pressure ulcers (Modified Norton or RAPS-scale) is carried out according to the hospital usual routine. Examination with PU sensor will be performed.

Evaluation/visit 2: Takes place in connection with the discharge from the hospital or 4 weeks after visit 1 if the research subject is still hospitalized. Full body skin inspection to see possible onset of pressure ulcers. Review of the research subject's medical records as well as review of nursing notes from the hospital where the research subject has been discharged from, to find any notes about pressure ulcers. The study participation is then terminated for the research subject.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pressure Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Double blind
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

The medical device will give an ID number but the results from the measurement will be masked until data base is locked (DBL). The data from the measurement will be available after DBL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PU Sensor examination

Device:PU Sensor will assess the microcirculation in sacrum with and without pressure (subject will lay on side and after that on back) the total measurement time is 5-10 minutes

Group Type OTHER

PU sensor

Intervention Type DEVICE

Device to assess microcirculation in sacrum area to find subjects at risk for pressure ulcer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PU sensor

Device to assess microcirculation in sacrum area to find subjects at risk for pressure ulcer

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Given their written consent to participate in the study
2. Male or female between ≥18 years and ≤ 64 years with a reduced mobility, where the hospitalization may involve a risk that the person may become less active or Male or female ≥65 years

Exclusion Criteria

1. Existing pressure ulcer or damage to the skin around the sacrum where the PU sensor plate and pillow are to be placed
2. Fever ≥38 ºC, within 30 minutes before the examination with PU sensor
3. Difficulty lying still in supine position during the examination with PU sensor, which takes 5 to 10 minutes
4. Known allergy or sensitivity to any of the materials in PU sensor that gets in contact with the skin on the sacrum
5. Body weight ≥200 kg
6. Previous participation in the study
7. Mental inability, or language difficulties that results in difficulty to understand the meaning of participation in the study and / or signing the study consent,
8. Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aurevia

INDUSTRY

Sponsor Role collaborator

PU sensor AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna-Christina Ek, RN,PhD

Role: STUDY_CHAIR

PU Sensor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Länssjukhuset Ryhov, Geriatriska kliniken

Jönköping, , Sweden

Site Status

Oskarhamns Sjukhus

Oskarshamn, , Sweden

Site Status

Medicin-Geriatriska kliniken Akademiska sjukhuset,

Uppsala, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIP-PUS-1-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prospective Biceps Study
NCT01317719 COMPLETED